MICHAEL A. KAHN, D.D.S. Professor and Chair, Department of Oral and Maxillofacial Pathology, Tufts University School of Dental Medicine; Laboratory Director, Tufts Oral Pathology Services; Diplomate, American Board of Oral and Maxillofacial Pathology
SCOTT D. BENJAMIN, D.D.S. Full-time private practice, Sidney, NY; Visiting professor, SUNY Buffalo School of Dental Medicine, Research Associate NYU College of Dentistry.
SOOK-BIN WOO, D.M.D. Associate Professor, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine; Director of Clinical Affairs, Division of Oral Medicine and Dentistry, Brigham and Women’s Hospital
DANIEL OREADI, D.M.D. Assistant Professor, Department of Oral and Maxillofacial Surgery at Tufts University School of Dental Medicine – Tufts Medical Center
RICHARD O. WEIN, M.D. Associate Professor of Otolaryngology—Head & Neck Surgery Residency Program Director; Director of the Division of Head and Neck Surgery, Tufts Medical Center
Oral cancer remains the most common disfiguring and deadly disease that a dentist, whether generalist or specialist, is likely to encounter during their practice of dentistry. This course provides the clinician with the knowledge to enhance their ability to recognize early potentially malignant or malignant changes within the oral cavity and effectively communicate and refer their patient for follow-up management. Furthermore, following treatment of oral cancer, this course discusses the complex nature of that treatment and the complications that can ensue as well as their implications that the dentist must be prepared for.
- Know the features and limitations of the current spectrum of oral soft tissue mucosal diagnostic adjuncts and how a general dentist may appropriately use them in their practice
- Learn the oral complications of oral cancer chemotherapy and its implications for the dentist
- Learn the complications associated with the surgical and medical management of oral-head and neck cancer
- Understand the management of late detection stage IV oral cancer